3545 John Hopkins Court Suite 200

San Diego, CA 92121


© 2019 LOCANA     , Inc.

All rights reserved.


Pioneering RNA-targeting gene therapies

Addressing human genetic disease by targeting RNA


Mutations in our DNA can cause disease and our RNA-targeting technology platform allows us to precisely  address these mutations. By targeting RNA, our approach avoids the risk of off-target effects in DNA and is suited to address many diseases linked to dysfunctional processing of RNA.  We are focused on realizing the potential of our RNA-targeting gene therapy platform to treat a range of devastating illnesses.


James Burns, PhD

Chief Executive Officer

Ron Batra, PhD

Vice President, R&D

Kathie Bishop, PhD

Chief Scientific Officer

Jill Martin

Head of IP and

Patent Strategy

Micah Mackison

Chief Business Officer

Samantha Murphy, PhD

Director, Corporate Development

Gene Yeo, PhD, MBA

Scientific Advisor




December 10, 2019 - Press Release

Locana Expands Leadership Team with Appointment of former Casebia CEO, James Burns, Ph.D., as Chief Executive Officer

San Diego,  CA -- Locana, Inc., a leading RNA-targeting gene therapy company, today announced...

September 23, 2019 - Press Release

Biocom Announces Fourth Annual Catalyst Award Winners

San Diego,  CA -- Biocom, the association representing the California life science industry, today...

September 4, 2019 - Press Release

Locana Appoints Kathie Bishop, Ph.D., as Chief Scientific Officer

San Diego,  CA -- Locana, a leading RNA-targeting gene therapy company, today announced...

June 12, 2019 - Press Release

MDA Awards Venture Philanthropy Grant to Locana to Develop Novel

Treatment for Muscular Dystrophy

New York, NY and San Diego,  CA -- The Muscular Dystrophy Association (MDA) and Locana, a leading...

May 22, 2019 - Press Release

Locana Raises $55 Million Series A Financing to Advance Portfolio of RNA-targeting Gene Therapies

San Diego, CA -- Locana Raises $55 Million Series A Financing to Advance Portfolio of RNA-targeting...

August 10, 2017 - News Coverage, Fierce Biotech

RNA-targeting CRISPR could yield treatments for Huntington's, ALS

Researchers from the University of California, San Diego, have used a new version of the gene editing...

October 5, 2017 - News Coverage, MIT Technology Review

Arming Bodies with CRISPR to Fight Huntington’s Disease and ALS

The editing tool normally targets DNA, but scientists are aiming it at a different molecule...

August 13, 2017 - News Coverage, Engadget

Gene editing technique could treat ALS and Huntington's disease

It might delay the onset of conditions that are normally inescapable...

December 12, 2016 - News Coverage, Discover

Top 100 Stories of 2016: CRISPR Edits Cells' RNA

It's a first step toward treating diseases like muscular dystrophy and neurodegeneration...

Add me to the distribution list